share_log

Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Flynn James E

SEC ·  Jun 4 06:36
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more